妊娠中の肝臓疾患 妊娠中の肝臓疾患
Deepak Joshi1, Andra James, Alberto Quaglia
1Institute of Liver Studies, King's College Hospital, London, UK.
Lancet (London, England)
|February 18, 2010
まとめ
妊娠に関連した肝疾患は稀であるが,母親と胎児に重大なリスクをもたらす. 早期診断と病原性に関する最新の研究は,肝機能不全の妊婦の治療結果を改善するために不可欠です.
科学分野:
- 産婦人科と産婦人科を担当しています.
- 肝臓病理学 肝臓病理学
- 妊産婦・胎児医学について
背景:
- 妊娠中の重度の肝疾患はまれですが,母と胎児の両方の健康に重大な危険性があります.
- 妊娠に関連した肝臓疾患は,妊娠中の肝臓機能不全の主要な原因です.
- 妊娠に関連した肝疾患と関連のない肝疾患の間に合った区別は,効果的な管理に不可欠です.
研究 の 目的:
- 妊娠中に発生する肝臓疾患の総合的な概要を提供するため.
- 妊娠に関連した肝疾患の基礎となる病原性メカニズムに関する知識を更新する.
- これらの状態の管理のための現在の治療戦略を評価する.
主な方法:
- 妊娠に関連した肝疾患に関する文献レビュー.
- 病原性メカニズムの分析. 病原性メカニズムの分析.
- 治療選択肢の評価.
主要な成果:
- 妊娠に関連した肝疾患は,母体および胎児の死亡率の重要な原因です.
- パトジェネシスの理解における進歩は,より良い臨床結果につながりました.
- 診断と治療の戦略は,進化し続けています.
結論:
- 効果的な管理には,迅速かつ正確な診断が必要です.
- 病原性に関する継続的な研究は,母と胎児の生存率を改善するために不可欠です.
- 診断と治療の総合的なアプローチが推奨されます.
関連する概念動画
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...


